588 related articles for article (PubMed ID: 16772739)
21. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
22. The investigation of a heart valve patient with suspected hypercoagulability.
Gough SC; Prentice CR
J Heart Valve Dis; 1993 Jan; 2(1):7-17. PubMed ID: 8269113
[TBL] [Abstract][Full Text] [Related]
23. Alterations of platelet, coagulation, and fibrinolysis markers in patients with acute ischemic stroke.
Uchiyama S; Yamazaki M; Hara Y; Iwata M
Semin Thromb Hemost; 1997; 23(6):535-41. PubMed ID: 9469626
[TBL] [Abstract][Full Text] [Related]
24. Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin.
Li N; He S; Blombäck M; Hjemdahl P
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):407-13. PubMed ID: 17138937
[TBL] [Abstract][Full Text] [Related]
25. Activation of coagulation and fibrinolysis in microsurgical reconstructions in the lower extremities.
Olsson E; Svartling N; Asko-Seljavaara S; Lassila R
Br J Plast Surg; 2001 Oct; 54(7):597-603. PubMed ID: 11583496
[TBL] [Abstract][Full Text] [Related]
26. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
Ray MJ; Marsh NA; Hawson GA
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673
[TBL] [Abstract][Full Text] [Related]
27. The influence of the duration of cardiopulmonary bypass on coagulation, fibrinolysis and platelet function.
Wahba A; Rothe G; Lodes H; Barlage S; Schmitz G
Thorac Cardiovasc Surg; 2001 Jun; 49(3):153-6. PubMed ID: 11432473
[TBL] [Abstract][Full Text] [Related]
28. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
Undas A; Kolarz M; Kopeć G; Tracz W
Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
[TBL] [Abstract][Full Text] [Related]
29. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells.
Sitter T; Spannagl M; Schiffl H; Held E; van Hinsbergh VW; Kooistra T
Nephrol Dial Transplant; 1995; 10(5):677-83. PubMed ID: 7566582
[TBL] [Abstract][Full Text] [Related]
30. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
[TBL] [Abstract][Full Text] [Related]
31. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
32. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA
Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
[TBL] [Abstract][Full Text] [Related]
33. Significance of blood coagulation and platelet profiles in relation to pulmonary thrombosis in beta-thalassemia/Hb E.
Visudhiphan S; Ketsa-Ard K; Tumliang S; Piankijagum A
Southeast Asian J Trop Med Public Health; 1994 Sep; 25(3):449-56. PubMed ID: 7777905
[TBL] [Abstract][Full Text] [Related]
34. Dialyzers designed to increase internal filtration do not result in significantly increased platelet activation and thrombin generation.
Vernon K; Peasegood J; Riddell A; Davenport A
Nephron Clin Pract; 2011; 117(4):c403-8. PubMed ID: 21071966
[TBL] [Abstract][Full Text] [Related]
35. The fibrinolytic system in chronic renal failure.
Lottermoser K; Petras S; Pöge U; Fimmers R; Hertfelder HJ; Schiermeyer B; Vetter H; Düsing R
Eur J Med Res; 2001 Sep; 6(9):372-6. PubMed ID: 11591527
[TBL] [Abstract][Full Text] [Related]
36. Coagulation and fibrinolytic activity in Behçet's disease.
Hampton KK; Chamberlain MA; Menon DK; Davies JA
Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic fibrinogen infusion in cardiac surgery patients: effects on biomarkers of coagulation, fibrinolysis, and platelet function.
Karlsson M; Ternström L; Hyllner M; Baghaei F; Skrtic S; Jeppsson A
Clin Appl Thromb Hemost; 2011 Aug; 17(4):396-404. PubMed ID: 20530054
[TBL] [Abstract][Full Text] [Related]
38. The in vitro effects of Xancor, a synthetic astaxanthine derivative, on hemostatic biomarkers in aspirin-naïve and aspirin-treated subjects with multiple risk factors for vascular disease.
Serebruany V; Malinin A; Goodin T; Pashkow F
Am J Ther; 2010; 17(2):125-32. PubMed ID: 20305399
[TBL] [Abstract][Full Text] [Related]
39. The role of platelets and leukocytes in coagulation and fibrinolysis.
Cucuianu M; Trif I
Rev Roum Physiol (1990); 1992; 29(1-2):33-8. PubMed ID: 1472550
[TBL] [Abstract][Full Text] [Related]
40. Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease.
Mörtberg J; Blombäck M; Wallén Å; He S; Jacobson SH; Spaak J
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):401-7. PubMed ID: 26650459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
